2016 Publications

2016

Patel N, Willis A, Stone M, Barber S, Gray L, Davies M, Khunti K. Developing a Conceptually Equivalent Type 2 Diabetes Risk Score for Indian Gujaratis in the UK. Journal of Diabetes Research 2016, 9 pages, Article ID 8107108 http://dx.doi.org/10.1155/2016/8107108

Simmons RK, Borch-Johnson K, Lauritzen T, Rutten GEHM, Sandbaek A, Van Den Donk M, Black J, Tao L, William E, Davies MJ, Khunti K, Sharp S, Wareham N, Griffin S. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on five-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the ADDITION-Europe study Health Technol Assess 2016 Aug;20(64):1-86. doi: 10.3310/hta20640 PMID: 27583404

Khunti K, Gillies C, Dallosso H, Brady E, Gray LJ, Kilgallen G, Willis A, Zafar A, Davies MJ. Assessment of response rates and yields for Two opportunistic Tools for Early detection of Non-diabetic hyperglycaemia and Diabetes (ATTEND). A randomised controlled trial and cost-effectiveness analysis. Diabetes Research and Clinical Practice (2016), Available Online 6th May 2016, doi:http://dx.doi.org/10.1016/j.diabres.2016.04.054

Dhalwani NN, Zaccardi F, O'Donovan G, Carter P, Hamer M, Yates T, Davies MJ, Khunti K. Association between lifestyle factors and the incidence of multimorbidity in an older English population. J Gerontol A Biol Sci Med Sci (2016) doi: 10.1093/gerona/glw146, First published online: July 28, 2016

Gray L, Yates T, Troughton J, Khunti K, Davies MJ. Engagement, retention, and progression to type 2 diabetes: a retrospective analysis of the cluster-randomized "Let's Prevent Diabetes" trial". PLoS Medicine 2016, July 12 http://dx.doi.org/10.1371/journal.pmed.1002078 [Accepted Article 3 June 2016]

Davies MJ, Chatterjee S, and Khunti K (2016). The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies. Clinical Pharmacology: Advances and Applications. 2016 Jun 23;8:61-81. doi: 10.2147/CPAA.S82008. eCollection 2016 PMID: 27382388

Chatterjee S, Khunti K, Davies MJ. Optimizing Management of Glycaemia. Best Practice & Research: Clinical Endocrinology and Metabolism (2016), In Press, Accepted Manuscript, Available online 13 June 2016, doi:10.1016/j.beem.2016.06.002

Zaccardi F, Davies MJ, Dhalwani NN, Webb DR, Housley G, Shaw D, Hatton JW, Khunti K. Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study. Lancet Diabetes Endocrinol. 2016 Jun 9. pii: S2213-8587(16)30091-2. doi: 10.1016/S2213-8587(16)30091-2. [Epub ahead of print] PMID: 27293218

Khunti K, Chatterjee S, Carey M, Daly H, Batista-Ferrer H, and Davies MJ. New drug treatments versus structured education programmes for type 2 diabetes: comparing cost-effectiveness. Lancet Diabetes Endocrinol. 2016 May 24. Epub ahead of print. DOI: 10.1016/S2213-8587(16)30048

Rowlands AV, Yates T, Khunti K, Davies MJ, Edwardson CL. Raw accelerometer data analysis with GGIR R-package: Does accelerometer brand matter? Med Sci Sports Exerc. 2016 May 13. [Accepted Manuscript online]. DOI: 10.1249/MSS.0000000000000978. PMID: 27183118

Davies MJ, Russel-Jones D, Selam JL, Bailey TS, Kerenyi Z, Luo J, Bue-Valleskey J, Ivanyi T, Hartman ML, Jacobson J, Jacober SJ for IMAGINE 2 Study Investigators. Basal Insulin Peglispro vs Insulin Glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trial. Diabetes Obesity and Metabolism, Accepted manuscript online: 28 Jun 2016, DOI: 10.1111/dom.12712 PMID: 27349219

Punthakee Z, Gerstein CH, Bosch J, Tyrwhitt J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Probstfield J, Ramachandran A, Riddle Rydén LE, Badings EA, Birkeland KI, Cardona E, Comeerford P, Davies MJ, et al. (2016). Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE). Diabetes Care 39(5), 709–716. [Epub ahead of print: 2015 Dec 17.] DOI: 10.2337/dc15-1676. PMID: 26681720

O’Donovan G, Bakrania K, Ghouri N, Yates T, Gray L, Hamer M, Stamatakis E, Khunti K, Davies MJ, Sattar N, and Gill J (2016). Nonexercise Equations to Estimate Fitness in White European and South Asian Men. Med Sci Sports Exerc. 48(5), 854-859. [Accepted manuscript online: 2015 Dec 21.] DOI: 10.1249/MSS.0000000000000836. PMID: 26694847.

Henson J, Davies MJ, Bodicoat D, Edwardson C, Gill J, Stensel D, Tolfrey K, Dunstan D, Khunti K, Yates T. Breaking up prolonged sitting with standing or walking attenuates the postprandial metabolic response in post-menopausal women: A randomised acute study. Diabetes Care. 2016 Jan;39(1):130-8. doi: 10.2337/dc15-1240. Epub 2015 Dec 1. PMID:26628415

Edwardson C, Rowlands A, Bunnewell S, Sanders J, Esliger D, Gorely T, O’Connell S, Davies MJ, Khunti K, Yates T. Accuracy of posture allocation algorithms for thigh and waist-worn accelerometers. Med Sci Sports Exerc. 2016 Jan 7. [Epub ahead of print], DOI: 10.1249/MSS.0000000000000865. PMID:26741122

Khunti K, Bodicoat D, Davies MJ (2016). Type 2 diabetes: lifetime risk of advancing from prediabetes. Comment on: "Lifetime risk of progression from prediabetes to type 2 diabetes: a prospective cohort study", by by Ligthart et al, Lancet Diabetes Endocrinol. 4(1) 44-55. Lancet Diabetes Endocrinol. 2016 Jan;4(1):5-6. doi: 10.1016/S2213-8587(15)00394-0. Epub 2015 Nov 11. PMID: 26575607.

Khunti K, Nikolajsen A, Thorsted BL, Andersen M, Davies MJ, Paul SK. Clinical inertia with regard to intensifying therapy among people with type 2 diabetes treated with basal insulin. Diabetes Obes Metab. 18(4), 401-9. [Epub ahead of print: 2016 Feb 9.] [Accepted Manuscript online: 2016 Jan 7.] DOI: 10.1111/dom.12626. PMID:26743666

Bakrania K, Edwardson CL, Bodicoat DH, Esliger DW, Gill JMR, Kazi A, Velayudhan L, Sinclair AJ, Sattar N, Biddle SJH, Khunti K, Davies MJ, and Yates T (2016). Associations of mutually exclusive categories of physical activity and sedentary time with markers of cardiometabolic health in English adults: a cross-sectional analysis of the Health Survey for England. BMC Public Health Jan 12, 16(1), 25. DOI 10.1186/s12889-016-2694-9. PMID: 26753523.

Davies MJ, Sasaki T, Gross J, Bantwal G, Ono Y, Nishida T, Tojjar D, Seino H (2016). Comparison of insulin degludec with insulin detemir in type 1 diabetes: a 1-year treat-to-target trial. Diabetes, Obesity & Metabolism, 18:(1),96-99. (online 2015 Oct 19) DOI: 10.1111/dom.12573. PMID:26435472

Dhalwani N, O’Donovan G, Zaccardi F, Hamer M, Yates T, Davies MJ, Khunti K. Long term trends of multimorbidity and association with physical activity in older English population. International Journal of Behavioural Nutrition and Physical Activity 13(8) 18 Jan 2016. doi:10.1186/s12966-016-0330-9.

Herring L, Stevinson C, Davies MJ, Biddle S, Sutton C, Bowrey D, Carter P. Changes in physical activity behaviour and physical function after bariatric surgery: a systematic review and meta-analysis. Obes Rev. 17(3), 250-61. [Epub ahead of print: 2016 Jan 18.] DOI: 10.1111/obr.12361. PMID:26783103

Henson J, Dunstan D, Davies MJ, Yates T (2016). Sedentary behaviour as a new behavioural target in the prevention and treatment of type 2 diabetes. Diabetes Metab Res Rev. 32 (Suppl S1), 213-20. DOI: 10.1002/dmrr.2759. PMID: 26813615.

Gururaj SS, Crasto W, Jarvis J, Khunti K, Davies MJ. New insulins and newer insulin regimes: a review of their role in improving glycaemic control in patients with diabetes. Postgrad Med J. 92(1085), 152-164. [Epub ahead of print: 2016 Feb 03.] DOI: 10.1136/postgradmedj-2015-133716. PMID: 26842973

Ali S, Davies MJ, Gray L, Dales J, Brady E, Khunti K, Beshyah S, Hanif W. Guidelines for managing diabetes in Ramadan. Diabet Med. Jan 23. [Accepted manuscript online.] [Early View ahead of print: 2016 Feb 25.] DOI: 10.1111/dme.13080. PMID: 26802436.

Zaccardi F, Webb DR, Yates T, and Davies MJ (2016). Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 92:1084, 63-69. [Epub ahead of print: 2015 Nov 30.] DOI: 10.1136/postgradmedj-2015-133281. PMID: 26621825.

Seidu S, Walker N, Bodicoat DH, Davies MJ, and Khunti K (2016). A systematic review of interventions targeting primary care or community based professionals on cardio-metabolic risk factor control in people with diabetes. Diabetes Res Clin Pract. 113, 1-13. [Accepted manuscript online: 2016 Jan 21.] [Epub ahead of print: 2016 Feb 3.] DOI: 10.1016/j.diabres.2016.01.022.

Zaccardi F, Htike ZZ, Webb D, Khunti K, Davies MJ (2016). Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments. A Systematic Review and Network Meta-analysis. Ann Intern Med. 164(2), 102-13. [Epub ahead of print: 2015 Dec 8.] DOI:10.7326/M15-1432. PMID: 26642233

Davies MJ, Bain S, Atkin SL, Rossing P, Scott D, Shamkhalova MS, Bosch-Traberg H, Syrén A, Umpierrez GE. Efficacy and Safety of Liraglutide versus Placebo as Add-on to Glucose Lowering Therapy in Patients with Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial. Diabetes Care. 2016 Feb;39(2):222-30. doi: 10.2337/dc14-2883. Epub 2015 Dec 17. PMID: 26681713

Davies MJ, Gray L, Troughton J, Gray A, Tuomilehto J, Farooqi A, Khunti K, Yates T, On behalf of the Let’s Prevent Diabetes Team (2016). A Community Based Primary Prevention Programme for Type 2 Diabetes Integrating Identification and Lifestyle Intervention for Prevention: The Let’s Prevent Diabetes Cluster Randomised Controlled Trial. Preventive Med. 84, 48-56. [Uncorrected Proof online: 2015 Dec 29.] [Final version online: 2016 Feb 02] DOI: 10.1016/j.ypmed.2015.12.012. PMID: 26740346

Edwardson CL, Winkler EAH, Bodicoat DH, Yates T, Davies MJ, Dunstan DW, and Healy GN (2016). Considerations when using the activPAL monitor in field based research with adult populations. J Sport Health Sci. 2016 Feb 3. Uncorrected proof online. In Press. DOI: 10.1016/j.jshs.2016.02.002.

Bodicoat D, Khunti K, Srinivasan B, Mostafa S, Gray LJ, Davies MJ, Webb D. Incident Type 2 diabetes and the effect of early regression to normoglycaemia in a population with impaired glucose regulation. Diabet Med. 2016 Feb 12. [Accepted manuscript online] In Press. DOI: 10.1111/dme.13091. PMID: 26871995.

Seidu S, Achana F, Gray L, Davies MJ, Khunti K (2016). Effects of glucose lowering and multifactorial interventions on cardiovascular and mortality outcomes - A Meta-analysis of randomised control trials. Diab Med. 33(3), 280-289. DOI: 10.1111/dme.12885. PMID: 26282461.

Zaccardi F, Webb D, Htike ZZ, Youssef D, Khunti K, Davies MJ. Efficacy and safety of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes mellitus. Diabetes, Obesity and Metabolism, Accepted Article online: 5th April 2016, doi: 10.1002/dom.12670.

Beshyah S, Chatterjee S, Davies MJ (2016). Use of SGLT2 inhibitors during Ramadan: A survey of physicians’ views and practical guidance. Br J Diabetes 2016;16(1):20-24, doi.org/10.15277/bjd.2016.058.

Punthakee Z, Gerstein CH, Bosch J, Tyrwhitt J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Probstfield J, Ramachandran A, Riddle Rydén LE, Badings EA, Birkeland KI, Cardona E, Comeerford P, Davies MJ, et al. (2016). Cardiovascular and other outcomes post-intervention with insulin glargine and omega-3 fatty acids (ORIGINALE). Diabetes Care 39(5), 709–716. [Epub ahead of print: 2015 Dec 17.] DOI: 10.2337/dc15-1676. PMID:26681720

Barnard K, Crabtree V, Adolfsson P, Davies MJ, Kerr D, Kraus A, Gianferante D, Bevilacqua E, Serbedzija G. Impact of Type 1 Diabetes Technology on Family Members/Significant Others of People With Diabetes. J Diabetes Sci Technol. 2016 Apr 25. pii: 1932296816645365. [Epub ahead of print]. PMID: 27118728

Davies MJ, Glah D, Chubb B, Konidaris G, McEwan P. Cost-effectiveness of IDegLira versus alternative basal insulin intensification therapies in patients with type 2 diabetes uncontrolled on basal insulin in a UK setting. Pharmacoeconomics. 2016 Sep;34(9):953-66. doi: 10.1007/s40273-016-0433-9. PMID: 27438706

Htike ZZ, Yates T, Brady E, Webb D, Gray LJ, Swarbrick D, McCann G, Khunti K, Davies MJ. Rationale and design of the randomised controlled trial to assess the Impact of Liraglutide on cardiac function and structure in Young adults with type 2 Diabetes (The LYDIA Study). Cardiovasc Diabetol. 2016 Jul 21;15(1):102. doi: 10.1186/s12933-016-0421-6. PMID: 27440110

Dhalwani NN, Zaccardi F, O'Donovan G, Carter P, Hamer M, Yates T, Davies MJ, Khunti K. Association between lifestyle factors and the incidence of multimorbidity in an older English population. J Gerontol A Biol Sci Med Sci (2016) doi: 10.1093/gerona/glw146, First published online: July 28, 2016. PMID: 27470302

Willis A, Roshan M, Patel N, Gray L, Davies MJ, Khunti K. A community faith centre based screening and educational intervention to reduce the risk of type 2 diabetes: A feasibility study. Diabetes Res Clin Pract. 2016 Aug 6;120:73-80. doi: 10.1016/j.diabres.2016.07.025. [Epub ahead of print]. PMID: 27522562

Rosenstock J, Aronson R, Grunberger G, Hanefeld M, Piatti P, Serusclat P, Cheng X, Zhou T, Niemoeller E, Souhami E, Davies MJ on behalf of the LixiLan-O Study Investigators. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine plus Lixisenatide versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care Published Ahead of Print, published online August 15, 2016, doi:10.2337/dc16-0917/-/DC1. PMID: 27527848

Back to top

To main page

Share this page: